Apimeds Pharmaceuticals US APUS
NYSE APUS
$4.29 -0.10 (-2.28%)
At close: Aug 20, 2026 · 1:53 PM UTC

Apimeds Pharmaceuticals US (APUS) Return on Assets (QoQ) (2025)

Apimeds Pharmaceuticals US (APUS) Return on Assets (QoQ) (2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 43.94 Bn 42.97 Bn -
2 Teva Pharmaceutical Industries 43.08 Bn 39.43 Bn 2.15 Bn
3 Zoetis 31.54 Bn 29.87 Bn 1.05 Bn
4 Takeda Pharmaceutical 28.60 Bn 22.80 Bn 5.10 Bn
5 United Therapeutics 22.12 Bn 19.46 Bn 683.80 Mn
6 Viatris 18.75 Bn 17.86 Bn 1.46 Bn
7 Neurocrine Biosciences 15.50 Bn 15.11 Bn 935.80 Mn
8 Elanco Animal Health 11.69 Bn 11.16 Bn 798.00 Mn
9 Dr Reddys Laboratories 10.13 Bn 9.96 Bn -
10 Apimeds Pharmaceuticals US 7.35 Mn 7.35 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 0.00
Sep 30, 2025 0.00
Jun 30, 2025 11.00